EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer

Yang Li,1,* Yanhong Duo,2,3,* Shiyun Bao,1 Lisheng He,4 Kai Ling,5 Jinfeng Luo,4 Yue Zhang,1 Hao Huang,2 Han Zhang,2 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, 2Shenzhen Engineering Labor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Li Y, Duo Y, Bao SY, He L, Ling K, Luo J, Zhang Y, Huang H, Zhang H, Yu X
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
DM1
Acceso en línea:https://doaj.org/article/152eb00601a148f1a5541d2a34ee3be1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:152eb00601a148f1a5541d2a34ee3be1
record_format dspace
spelling oai:doaj.org-article:152eb00601a148f1a5541d2a34ee3be12021-12-02T05:10:42ZEpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer1178-2013https://doaj.org/article/152eb00601a148f1a5541d2a34ee3be12017-08-01T00:00:00Zhttps://www.dovepress.com/epcam-aptamer-functionalized-polydopamine-coated-mesoporous-silica-nan-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yang Li,1,* Yanhong Duo,2,3,* Shiyun Bao,1 Lisheng He,4 Kai Ling,5 Jinfeng Luo,4 Yue Zhang,1 Hao Huang,2 Han Zhang,2 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, 2Shenzhen Engineering Laboratory of Phosphorene and Optoelectronics, Collaborative Innovation Center for Optoelectronic Science and Technology, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, 3Key Laboratory of Plant Cell Activities and Stress Adaptation, Ministry of Education, School of Life Sciences, Lanzhou University, Lanzhou, 4Department of Pathology, 5Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, China *These authors contributed equally to this work Abstract: DM1, a maytansine derivative, is a highly potential cytotoxic agent but with severe side effects; therefore, its application in clinical cancer therapy is limited. Here, in order to mitigate this intrinsic drawback of DM1, we developed mesoporous silica nanoparticles (MSNs) loaded with DM1 and surface-decorated with hydrochloride dopamine (PDA), polyethylene glycol (PEG), and epithelial cell adhesion molecule (EpCAM) aptamer (APt) for the targeted treatment of colorectal cancer (CRC). In this system, the PDA coating could be used as pH-sensitive gatekeepers to control the release of DM1 from MSNs in response to the pH stimulus and EpCAM APt-guided active targeting enables the increased delivery of DM1 to CRC as well as a reduction in toxicity and side effects by minimizing the exposure of normal tissues to DM1. Results demonstrated that DM1 inhibited the formation of microtubules and induced apoptosis in tumor cells via caspase signaling. In comparison with the control groups, the MSNs-DM1@PDA-PEG-APt bioconjugates exhibited increased binding ability and much higher cytotoxicity to the CRC SW480 cell line. Furthermore, in vivo assays confirmed the advantages of such a strategy. These findings suggested that MSNs-DM1@PDA-PEG-APt could represent a promising therapeutic platform for EpCAM-positive CRC. Keywords: DM1, EpCAM aptamer, mesoporous silica nanoparticles, colorectal cancerLi YDuo YBao SYHe LLing KLuo JZhang YHuang HZhang HYu XDove Medical PressarticleDM1EpCAM aptamermesoporous silica nanoparticlescolorectal cancerMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 12, Pp 6239-6257 (2017)
institution DOAJ
collection DOAJ
language EN
topic DM1
EpCAM aptamer
mesoporous silica nanoparticles
colorectal cancer
Medicine (General)
R5-920
spellingShingle DM1
EpCAM aptamer
mesoporous silica nanoparticles
colorectal cancer
Medicine (General)
R5-920
Li Y
Duo Y
Bao SY
He L
Ling K
Luo J
Zhang Y
Huang H
Zhang H
Yu X
EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
description Yang Li,1,* Yanhong Duo,2,3,* Shiyun Bao,1 Lisheng He,4 Kai Ling,5 Jinfeng Luo,4 Yue Zhang,1 Hao Huang,2 Han Zhang,2 Xiaofang Yu1 1Department of Hepatobiliary and Pancreas Surgery, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, 2Shenzhen Engineering Laboratory of Phosphorene and Optoelectronics, Collaborative Innovation Center for Optoelectronic Science and Technology, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, 3Key Laboratory of Plant Cell Activities and Stress Adaptation, Ministry of Education, School of Life Sciences, Lanzhou University, Lanzhou, 4Department of Pathology, 5Institute of Respiratory Diseases, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen, China *These authors contributed equally to this work Abstract: DM1, a maytansine derivative, is a highly potential cytotoxic agent but with severe side effects; therefore, its application in clinical cancer therapy is limited. Here, in order to mitigate this intrinsic drawback of DM1, we developed mesoporous silica nanoparticles (MSNs) loaded with DM1 and surface-decorated with hydrochloride dopamine (PDA), polyethylene glycol (PEG), and epithelial cell adhesion molecule (EpCAM) aptamer (APt) for the targeted treatment of colorectal cancer (CRC). In this system, the PDA coating could be used as pH-sensitive gatekeepers to control the release of DM1 from MSNs in response to the pH stimulus and EpCAM APt-guided active targeting enables the increased delivery of DM1 to CRC as well as a reduction in toxicity and side effects by minimizing the exposure of normal tissues to DM1. Results demonstrated that DM1 inhibited the formation of microtubules and induced apoptosis in tumor cells via caspase signaling. In comparison with the control groups, the MSNs-DM1@PDA-PEG-APt bioconjugates exhibited increased binding ability and much higher cytotoxicity to the CRC SW480 cell line. Furthermore, in vivo assays confirmed the advantages of such a strategy. These findings suggested that MSNs-DM1@PDA-PEG-APt could represent a promising therapeutic platform for EpCAM-positive CRC. Keywords: DM1, EpCAM aptamer, mesoporous silica nanoparticles, colorectal cancer
format article
author Li Y
Duo Y
Bao SY
He L
Ling K
Luo J
Zhang Y
Huang H
Zhang H
Yu X
author_facet Li Y
Duo Y
Bao SY
He L
Ling K
Luo J
Zhang Y
Huang H
Zhang H
Yu X
author_sort Li Y
title EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
title_short EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
title_full EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
title_fullStr EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
title_full_unstemmed EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer
title_sort epcam aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with dm1 for targeted therapy in colorectal cancer
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/152eb00601a148f1a5541d2a34ee3be1
work_keys_str_mv AT liy epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT duoy epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT baosy epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT hel epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT lingk epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT luoj epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT zhangy epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT huangh epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT zhangh epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
AT yux epcamaptamerfunctionalizedpolydopaminecoatedmesoporoussilicananoparticlesloadedwithdm1fortargetedtherapyincolorectalcancer
_version_ 1718400514626945024